Emerging anabolic agents in the treatment of osteoporosis.

about

Emerging anabolic agents in the treatment of osteoporosis.

Item

http://www.wikidata.org/entity/Q48012226

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Emerging anabolic agents in the treatment of osteoporosis.

@en

Emerging anabolic agents in the treatment of osteoporosis.

@nl

type

Item

label

Emerging anabolic agents in the treatment of osteoporosis.

@en

Emerging anabolic agents in the treatment of osteoporosis.

@nl

prefLabel

Emerging anabolic agents in the treatment of osteoporosis.

@en

Emerging anabolic agents in the treatment of osteoporosis.

@nl

P1476

Emerging anabolic agents in the treatment of osteoporosis.

@en

P2093

Christina Lovato

http://www.w3.org/2001/XMLSchema#string

E Michael Lewiecki

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

P304

247-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14728214.2017.1362389

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28756709

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis